Schedule 13D ownership disclosure

SENTI BIOSCIENCES INC

Common Stock, $0.0001 par value · CUSIP: 81726A209

Event date: 2026-03-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • New Enterprise Associates 15, L.P.Reported CIK 0001629794

    Shares: 3,775,615.00 · Class: 12.1%

  • NEA Partners 15, L.P.Reported CIK 0001640031

    Shares: 3,775,615.00 · Class: 12.1%

  • NEA 15 GP, LLCReported CIK 0001640033

    Shares: 3,775,615.00 · Class: 12.1%

  • Forest BaskettReported CIK 0001277631

    Shares: 3,775,615.00 · Class: 12.1%

  • Anthony A. Florence, Jr.Reported CIK 0001559827

    Shares: 3,775,615.00 · Class: 12.1%

  • Mohamad H. MakhzoumiReported CIK 0001630226

    Shares: 3,775,615.00 · Class: 12.1%

  • Scott D. SandellReported CIK 0001237289

    Shares: 3,775,615.00 · Class: 12.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-26-000301
Form type
SCHEDULE 13D/A
Filer
New Enterprise Associates 15, L.P.
CIK
CIK 1629794
Filed
Mar 31, 2026
Reporting period
Mar 27, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub